Due to the strong expression correlation between RAI14 and enzymes associated with RA biosynthesis in colon cancer (supplemental Fig. S9, A–H), targeting the RA biosynthesis pathway to reduce the expression of RAI14 may be a promising therapeutic strategy for mAPC-II colon cancer patients. The gene discussed is RAI14; the disease is colonic neoplasm.